Biogen | BIIB - Action





Action Changement Date
AbbVie USD 4.95B 13M 2025-12
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Amgen USD 6.22B 121M 2025-12
Bayer EUR 12.33B 221M 2025-09
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Gilead Sciences USD 1.77B 11M 2025-12
Incyte USD 101.06M 17.61M 2025-12
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
United Therapeutics USD 183.1M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12